What Heartbeam Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 8 |
| Sells | 0 | 3 |
| Total trades | 0 | 18 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 4,548,550 |
| Disposed | 0 | 307,146 |
| Net activity | +0 | +4,241,404 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cruickshank Tim | CFO | Jul 24 | Grant / award · A | +167,760 | — | — | 239,990 |
| Vajdic Branislav | President | Jul 24 | Grant / award · A | +260,870 | — | — | 3,970,784 |
| Persen Kenneth Harry | Chief Technology Officer | Jul 24 | Grant / award · A | +105,740 | — | — | 448,290 |
| Vajdic Branislav | President | Jun 15 | Grant / award · A | +2,800,000 | — | — | 3,709,914 |
| Eno Robert Paul | President | Apr 16 | Open-market buy · P | +12,500 | $0.80 | +$10K | 36,742 |
| Vajdic Branislav | Director | Apr 16 | Open-market buy · P | +31,250 | $0.80 | +$25K | 909,914 |
| Jaff Michael R | Director | Apr 16 | Open-market buy · P | +31,250 | $0.80 | +$25K | 31,250 |
| Elfrink Willhem | Director | Apr 16 | Open-market buy · P | +187,500 | $0.80 | +$150K | 538,667 |
| Cruickshank Tim | CFO | Apr 16 | Open-market buy · P | +31,250 | $0.80 | +$25K | 72,230 |
| Ortigas-Wedekind Marga | Director | Apr 16 | Open-market buy · P | +25,000 | $0.80 | +$20K | 137,293 |
| Ferrari Richard M | Director | Apr 16 | Open-market buy · P | +57,500 | $0.80 | +$46K | 286,636 |
| Strome Mark E | Director | Apr 16 | Open-market buy · P | +750,000 | $0.80 | +$600K | 3,650,000 |
| Jaff Michael R | Director | Feb 09 | Grant / award · A | +20,689 | — | — | 95,809 |
| Ferrari Richard M | Director | Feb 09 | Grant / award · A | +50,000 | — | — | 229,136 |
| Nelson Kenneth Warwick Iii | Director | Feb 09 | Grant / award · A | +17,241 | — | — | 144,388 |
| Urioste George De | Director | Dec 18 | Open-market sale · S | −33,185 | $2.83 | −$93.9K | 0 |
| Strome Mark E | 10% owner | Dec 17 | Open-market sale · S | −250,000 | $3.58 | −$895K | 2,900,000 |
| Urioste George De | Director | Dec 17 | Sale for tax withholding · S | −23,961 | $3.68 | −$88.2K | 33,185 |
| Cruickshank Tim | CFO | Feb 14 | Open-market buy · P | +17,647 | $1.70 | +$30K | 17,647 |
| Ferrari Richard M | Director | Feb 14 | Open-market buy · P | +29,412 | $1.70 | +$50K | 179,136 |
Loading...
